LIVN
LivaNova PLC · Healthcare · Medical - Devices
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -11.5% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 98 | -4 | 44.19M | $3.62B | +8 | −13 |
| Q1 2026 | 106 | +4 | 47.23M | $2.90B | +11 | −8 |
| Q4 2025 | 101 | +1 | 45.33M | $2.77B | +2 | — |
| Q3 2025 | 19 | -1 | 27.90M | $1.46B | — | −2 |
| Q2 2025 | 18 | -1 | 26.29M | $1.18B | — | −1 |
| Q1 2025 | 16 | +1 | 14.79M | $580.16M | +1 | — |
| Q4 2024 | 15 | 0 | 15.31M | $708.67M | +1 | −1 |
| Q3 2024 | 14 | 0 | 15.20M | $798.66M | +1 | −1 |
| Q2 2024 | 14 | — | 15.53M | $851.55M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 4.75M | -15.5% | $220.16M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 2 | Millennium Management ✦ | 3.05M | +3.1% | $141.18M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passive) | 2.10M | — | $97.25M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 1.34M | -0.6% | $61.94M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 5 | Point72 Asset Management ✦ | 1.04M | -50.5% | $47.99M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 742.18K | +79.3% | $34.21M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 7 | Marshall Wace ✦ | 725.59K | +49.2% | $33.60M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | D. E. Shaw & Co. ✦ | 504.36K | +12.9% | $23.36M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 9 | Two Sigma Investments ✦ | 439.58K | +27.2% | $20.36M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 192.12K | New | $8.90M | 0.0% | New | 1 | SEC ↗ ×3 |
| 11 | Citadel Advisors ✦ | 164.01K | -74.8% | $7.60M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 12 | Renaissance Technologies ✦ | 112.59K | +9.2% | $5.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Norges Bank ✦ (passive) | 84.75K | 0.0% | $3.92M | 0.0% | Held | 3 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 37.18K | +11.5% | $1.72M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 27.22K | +206.5% | $1.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Wellington Management | $8.90M | 0.0% |
Exited
| Greenlight Capital (DME… | $31.71M | was 1.3% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 289 holders, 58.28M shares, $3.62B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 3.50K sh · $273,032
Director · 2.30K sh · $187,270
Director · 1.65K sh · $131,538
Officer · 2.67K sh · $207,942
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology